A member of the NSABB biosecurity board that recently reviewed H5N1 data criticizes the process.
Daily News Roundup
A member of the NSABB biosecurity board that recently reviewed H5N1 data criticizes the process.
Despite government efforts to ban unapproved stem cell treatments, companies around China still offer them openly.
Swedish researchers have discovered that patients with the neurodegenerative disorder had half the normal expected risk of developing tumors.
A new law opens the door to teaching creationism and climate change denialism in the state's public schools.
A vaccine that targets 90 percent of all cancers shows promise in early clinical trials.
The US Supreme Court has asked the Obama administration to weigh in on a petition concerning Monsanto’s Roundup Ready seeds.
The European Medicines Agency revised its policy on conflicts of interest in response to concerns regarding its ability to conduct independent evaluations.
Extra inches may mean a higher chance of getting ovarian cancer.
Researchers put the predictive power of whole genome sequencing to the test.
The FDA may require weight-loss drugs to undergo clinical trials to see if they pose a risk of heart attack.